Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

BioTelemetry Inc. (BEAT)

62.09 2.09 (3.48%)

11-15 16:00

Open:

59.5

Pre. Close:

60

High:

62.22

Low:

57.5

Volume:

475,442

Market Cap:

2068M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

62.365 - 62.778

62.778 - 63.151

Low:

56.53 - 57.03

57.03 - 57.483

Close:

61.27 - 62.106

62.106 - 62.862

Technical analysis  (as of: 2018-11-15 4:28:48 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 81.76     One year: 95.50

Support:

Support1: 55.97    Support2: 47.30

Resistance:

Resistance1: 70.00    Resistance2: 81.76

Pivot:

60.93

Moving Averages:

MA(5): 62.42     MA(20): 58.83

MA(100): 56.11     MA(250): 43.31

MACD:

MACD(12,26): 1.84     Signal(12,26,9): 1.69

%K %D:

%K(14,3): 59.30     %D(3): 62.88

RSI:

RSI(14): 54.61

52-Week:

High: 70  Low: 24.3  Change(%): 143.0

Average Vol(K):

3-Month: 52074  10-Days 74415

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BEAT has closed below upper band by 45.3%. Bollinger Bands are 162.8% wider than normal. The large width of the bands suggest high volatility as compared to BEAT's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

2018-10-31T11:49:33-04:00
BioTelemetry up 15% after Q3 beat, guidance raise

2018-10-30T22:35:15-04:00
BioTelemetry, Inc. (BEAT) CEO Joseph Capper on Q3 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostics Research

Shares Out. (M)

33.30

Shares Float (M)

31.10

% Held by Insiders

6.70

% Held by Institutions

161.40

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

1.700

EPS Est. Current Year

0.950

EPS Est. Next Year

1.290

EPS Est. Next Quarter

0.280

Forward EPS

1.500

Book Value (p.s.)

7.830

PEG Ratio

1.58

Profit Margin

3.94

Operating Margin

12.52

Return on Assets (ttm)

3.1

Return on Equity (ttm)

6.0

Qtrly Rev. Growth

69.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

505.10

Operating Cash Flow (M)

29.18

Levered Free Cash Flow (M)

36.81

Valuation

P/E

36.52

P/E Growth Ratio

0.03

P/BV

7.93

P/S

191090304.00

P/CF

70.86

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.